Eyerising International
Eyerising International is an Australian MedTech company developing life-impacting eye-health therapy to slow the progression of myopia.
Eyerising International sponsored articles.
Eyerising International myopia management products
Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.Eyerising Myopia Management Device
The Eyerising myopia management device uses proprietary technology for administering Repeated Low-Level Red-Light (RLRL) therapy that enhances blood circulation in the ocular fundus, addressing sclera hypoxia and managing the axial elongation associated with myopia. It is backed by 2-year clinical trial results showing myopia control efficacy, and complies with Australian Standard IEC 60825-1:2014 for laser products safety.
Eyerising International resources
Eyerising Expert Video Interview Series Highlights
Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device.